Xiangyang Central Hospital: Clinical Trials & Research Profile
Hospital / Clinical Site in Xiangyang, China · Primary Specialty: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Clinical Trial Research Site |
| Institutional Sector & Location | Hospital / Clinical Site (Xiangyang, China) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 62 active (33 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 79 |
| Completed vs Early-Stopped Studies | 10 completed / 1 stopped (1.3% stop rate) |
| Median Closed Enrollment | 482 participants |
| Median Completed Study Duration | 1,158 calendar days |
| Physical Hospital Site Disclosure | 100.0% named hospital campus |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk